| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-09 | JPMORGAN CHASE & CO | Evolent Health, Inc. | 4,679,353 | 4.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Evolent Health, Inc. | 10,821,331 | 9.4% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Evolent Health, Inc. | 12,890,729 | 11.2% | EDGAR |
| SC 13G | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Evolent Health, Inc. | 8,313,157 | 7.2% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | Evolent Health, Inc. | 8,423,999 | 7.3% | EDGAR |
| SC 13G/A | 2024-01-18 | JPMORGAN CHASE & CO | Evolent Health, Inc. | 5,863,530 | 5.1% | EDGAR |
| SC 13G/A | 2023-04-26 | MAGELLAN HEALTH INC | Evolent Health, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-04-10 | FMR LLC | Evolent Health, Inc. | 14,641,699 | 13.2% | EDGAR |
| SC 13G/A | 2023-03-08 | UPMC | Evolent Health, Inc. | 2,190,702 | 2.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Granahan Investment Management, LLC | Evolent Health, Inc. | 3,155,211 | 3.1% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Evolent Health, Inc. | 9,790,816 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-03 | UPMC | Evolent Health, Inc. | 5,907,841 | 5.8% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | Evolent Health, Inc. | 7,701,919 | 7.6% | EDGAR |
| SC 13G | 2023-01-27 | MAGELLAN HEALTH INC | Evolent Health, Inc. | 8,474,576 | 8.4% | EDGAR |
| SC 13G/A | 2023-01-20 | JPMORGAN CHASE & CO | Evolent Health, Inc. | 5,368,825 | 5.3% | EDGAR |
| SC 13D/A | 2022-08-25 | Engaged Capital LLC | Evolent Health, Inc. | 2,585,187 | 2.8% | EDGAR |
| SC 13D/A | 2022-07-11 | Engaged Capital LLC | Evolent Health, Inc. | 2,936,627 | 3.2% | EDGAR |
| SC 13D/A | 2022-05-09 | Engaged Capital LLC | Evolent Health, Inc. | 3,989,962 | 4.4% | EDGAR |
| SC 13G | 2022-02-14 | Granahan Investment Management, LLC | Evolent Health, Inc. | 4,998,680 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Evolent Health, Inc. | 7,545,992 | 8.4% | EDGAR |